Summary
The inhibition of herpes simplex virus type 1 (strain McIntyre) by two antiherpes substances applied in combination was studied by means of a CPE inhibition method in Vero cell microcultures. The following substances were studied: AraA monophosphate, thymine arabinoside, ethyldeoxyuridine, acycloguanosine (acyclovir), 3-fluorothymidine, phosphonoformic acid. Most substance pairs showed a moderate degree of synergism. Two additive interactions and one case of antagonism was observed. Human fibroblast interferon, combined with the antiherpes substances, showed an additive interaction with AraAMP, but synergism with the others.
Similar content being viewed by others
References
Ayisi, N. K., Gupta, V. S., Meldrum, J. B., Taneja, A. K., Babiuk, L. A.: Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with adenine arabinoside, 5-ethyldeoxyuridine, 5-iododeoxyuridine, and phosphonoacetic acid against herpes simplex virus types 1 and 2. Antimicrob. Agents Chemother.17, 558–566 (1980).
Babiuk, L. A., Meldrum, B., Gupta, V. S., Rouse, B. T.: Comparison of the antiviral effects of 5-methoxymethyldeoxyuridine with 5-iododeoxyuridine, cytosine arabinoside, and adenine arabinoside. Antimicrob. Agents Chemother.8, 643–650 (1975).
Bryson, Y. J., Kronenberg, L. H.: Combined antiviral effects of interferon, adenine arabinoside, hypoxanthine arabinoside, and adenine arabinoside-5'-monophosphate in human fibroblast cultures. Antimicrob. Agents Chemother.11, 299–306 (1977).
Cho, C. T., Feng, K. K.: Combined effects of acycloguanosine and humoral antibodies in experimental encephalitis due to herpesvirus hominis. J. inf. Dis.142, 451 (1980).
Cho, C. T., Feng, K. K., Brahmacupta, N.: Synergistic antiviral effects of adenine arabinoside and humoral antibodies in experimental encephalitis due to herpesvirus hominis. J. inf. Dis.133, 157–167 (1976).
Danenberg, P. V.: Thymidylate synthetase — a target enzyme in cancer chemotherapy. Biochim. Biophys. Acta473, 73–92 (1977).
Daniel, M. D., Tamulevich, R., Bekesi, J. G., King, N. W., Falk, L. A., Silva, D., Holland, J. F.: Selective antiviral activity of human interferons on primate oncogenic and neurotropic herpesviruses. Int. J. Cancer27, 113–121 (1981).
De Clercq, E., Descamps, J., Verhelst, G., Walker, R. T., Jones, A. S., Torrence, P. F., Shugar, D.: Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus. J. inf. Dis.141, 563–573 (1980).
De Clercq, E., Kulikowski, T., Sugar, D.: The 5'-monophosphates of 5-propyl- and 5-ethyl-2'-deoxyuridine do not inhibit the replication of deoxythymidine kinase deficient (TK−) mutants of herpes simplex virus. Biochem. Pharmacol.29, 2883–2885 (1980).
Elion, G. B., Furman, P. A., Fyfe, J. A., de Miranda, P., Beauchamp, L., Schaeffer, J. J.: Selectivity of action of an antiherpetic agents, 9-(2-hydroxyethoxymethyl)guanine. Proc. Nat. Acad. Sci. U.S.A.74, 5716–5720 (1977).
Eriksson, B., Öberg, B.: Characteristics of herpesvirus mutants resistant to phosphonoformate and phosphonoacetate. Antimicrob. Agents Chemother.15, 758–762 (1978).
Fiala, M., Chow, A. W., Miyasaki, K., Guze, L. B.: Susceptibility of herpesviruses to three nucleoside analogues and their combinations and enhancement of the antiviral effect at acid pH. J. inf. Dis.129, 82–85 (1974).
Field, H., McMillan, A., Darby, G.: The sensitivity of acyclovir-resistant mutants of herpes simplex virus to other antiviral drugs. J. inf. Dis.143, 281–285 (1981).
Gauri, K. K. (ed.): Anti-Herpesvirus Chemotherapy: Experimental and Clinical Aspects. In: Advances in Ophthalmology, Vol. 58. Basel: S. Karger 1979.
Gauri, K. K.: Anti-herpesvirus polychemotherapy. Adv. Ophthalmol.38, 151 to 163 (1979).
Gentry, G. A., Aswell, J. F.: Inhibition of herpes simplex virus replication by AraT. Virology65, 294–296 (1975).
Hay, J., Brown, S. M., Jamieson, A. T., Rixon, F. J., Moss, H., Dargan, D. A., Subak-Sharpe, J. H.: The effect of phosphonoacetic acid on herpes viruses. In:Oxford, J. S., Drasar, F. A., Williams, J. D. (eds.), Chemotherapy of Herpes Simplex Virus Infections, 63–70. London: Academic Press 1977.
Kaufman, H. E.:In vivo studies with antiviral agents. Ann. N. Y. Acad. Sci.130, 168–180 (1965).
Kern, E. R., Glasgow, L. A., Overall, J. C., jr., Reno J. M., Boezi, J. A.: Treatment of experimental herpesvirus infections with phosphonoformate and some comparisons with phosphonoacetate. Antimicrob. Agents Chemother.14, 817–823 (1978).
Lazar, R., Breinig, M. K., Armstrong, J. A., Ho, M.: Response of cloned progeny of clinical isolates of herpes simplex virus to human leukocyte interferon. Infect. Imm.28; 708–712 (1980).
Lefkowitz, E., Worthington, M., Conliffe, McG. A., Baron, S.: Comparative effectiveness of six antiviral agents in herpes simplex type 1 infection of mice. Proc. Soc. exp. Biol.152, 337–342 (1976).
Lerner, A. M., Bailey, E. J.: Synergy of 9-β-D-arabinofuranosyladenine and human interferon against herpes simplex virus, type 1. J. inf. Dis.130, 549–552 (1974.)
Lerner, A. M., Bailey, E. J.: Differential sensitivity of herpes simplex virus types 1 and 2 to human interferon: antiviral effects of interferon plus 9-β-D-arabinofuranosyladenine. J. inf. Dis.134, 400–404 (1976).
Levin, M. J., Leary, P. L.: Inhibition of human herpesviruses by combination of acyclovir and human leukocyte interferon. Infect. Imm.32, 995–999 (1981).
Merigan, T. C., Robinson, W. S., Gregory, P. B., Smith, J. L., Pollard, R. B., Greenberg, H. B., Neal, E. A., Sawhney, V.: Antiviral therapy in hepatitis B infection. In: Abstracts of the 4th International Congress for Virology, The Hague (Centre for Agricultural Publishing and Documentation, Wageningen), p. 125, 1978.
Shannon, W. M., Schabel, F. M., jr.: Antiviral agents as adjuncts in cancer chemotherapy. Pharm. Ther.11, 263–390 (1980).
Smith, K. O., Kennell, W. L., Poirier, R. H., Lynd, F. T.:In vitro andin vivo resistance of herpes simplex virus to 9-(2-hydroxyethoxymethyl)guanine (acycloguanosine). Antimicrob. Agents Chemother.17, 144–150 (1980).
Stanwick, T. L., Schinazi, R. F., Campbell, D. E., Nahmias, A. J.: Combined antiviral effect of interferon and acyclovir on herpes simplex virus types 1 and 2. Antimicrob. Agents Chemother.19, 672–674 (1981).
Sundmacher, R, Cantell, K. Neumann-Haefelin, D.: Combination therapy of dendritic keratitis with trifluorothymidine and interferon. LancetII, 687, 1978.
Walker, R. T., de Clercq, E., Eckstein, F. (eds.): Nucleoside Analogues, Chemistry, Biology, and Medical Applications. New York-London: Plenum Press 1979.
Wigand, R.: Adenine arabinoside inhibition of adenovirus replication enhanced by an adenosine deaminase inhibitor. J. Med. Virol.4, 59–65 (1979).
Wigand, R., Hassinger, M.: Combined antiviral effect of DNA inhibitors on herpes simplex virus multiplication. Med. Microbiol. Immunol.168, 179–190 (1980).
Author information
Authors and Affiliations
Additional information
With 4 Figures
Rights and permissions
About this article
Cite this article
Janz, C., Wigand, R. Combined interaction of antiherpes substances and interferon β on the multiplication of herpes simplex virus. Archives of Virology 73, 135–143 (1982). https://doi.org/10.1007/BF01314722
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01314722